New Tool Better Estimates CV Risk in People With Lupus : vimarsana.com

A tool to estimate cardiovascular risk in systemic lupus erythematosus incorporates disease-specific variables.

Related Keywords

California , United States , Los Angeles , Eli Lilly , Maureen Mcmahon , University Of California , Glaxosmithkline , Werfen International , Medscape Professional Network , Lupus Clinical Trials Network , Astrazeneca , Aurinia Pharmaceuticals , Medscape Professional , Systemic Lupus Erythematosus , Le , Lupus , Lupus Nephritis , Cv , Ardiovascular , Artificial Intelligence , A I , I , Clinical Guidelines , Uidelines , Hospitals , Nephritis , Tissue , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Stroke , Erebrovascular Accident , Va Cerebrovascular Accident , Biomarker , Iological Marker , , Cardiovascular Disea ,